Philip C. Ranker
Finanzdirektor/CFO bei Bioness, Inc.
Profil
Philip C.
Ranker is currently the Chief Financial Officer & Secretary at Bioness, Inc. He previously worked as a Finance Director at ICOS Corp.
from 2001 to 2004, as a Senior Finance Director at Aventis Pharmaceuticals, Inc. from 1984 to 1999, as the Chief Financial Officer & Secretary at MDRNA, Inc. from 2004 to 2008, as the Vice President-Finance at Amylin Pharmaceuticals, Inc. from 2008 to 2009, as the Chief Financial Officer at Suneva Medical, Inc. from 2009 to 2011, as a Director at ImaRx Therapeutics, Inc. from 2006 to 2010, and as an Independent Director at Adhera Therapeutics, Inc. from 2014 to 2018.
He also worked as an Assistant Controller at Scholastic Corp.
from 1999 to 2000.
Mr. Ranker received his undergraduate degree from the University of Kansas.
Aktive Positionen von Philip C. Ranker
| Unternehmen | Position | Beginn |
|---|---|---|
Bioness, Inc.
 Bioness, Inc. Medical SpecialtiesHealth Technology Bioness, Inc. designs, develops, and manufactures medical devices. It offers devices designed for stroke, multiple sclerosis, traumatic brain injury, cerebral palsy, and spinal cord injury patients. The company was founded by Alfred Mann in 2004 and is headquartered in Valencia, CA. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Philip C. Ranker
| Unternehmen | Position | Ende |
|---|---|---|
| ADHERA THERAPEUTICS, INC. | Finanzdirektor/CFO | 22.07.2014 |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Finanzdirektor/CFO | 01.01.2011 |
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Direktor/Vorstandsmitglied | 01.01.2010 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.01.2009 |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Finanzdirektor/CFO | 04.01.2008 |
Ausbildung von Philip C. Ranker
| University of Kansas | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SCHOLASTIC CORPORATION | Consumer Services |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Bioness, Inc.
Bioness, Inc. Medical SpecialtiesHealth Technology Bioness, Inc. designs, develops, and manufactures medical devices. It offers devices designed for stroke, multiple sclerosis, traumatic brain injury, cerebral palsy, and spinal cord injury patients. The company was founded by Alfred Mann in 2004 and is headquartered in Valencia, CA. | Health Technology |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Technology |
